|Last Price$48.18||Day Change (%)-0.02%|
|Open Price$47.81||Day Change ($)-0.01|
|Day Range47.59–48.24||52-Week Range34.06–49.48|
As of Fri 10/21/2016 7:57:00 PM | USD
Global Antiemetic Drugs Market Report 2016-2021 - Analysis, Technologies & Forecasts - Vendors: Baxter , Novartis, Johnson & Johnson - Research and Markets
Global Leukemia Therapeutics Market Growth of 8.44% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Vendors: Novartis, AbbVie, Amgen - Research and Markets
Artificial Organs - Global Strategic Business Report 2016-2022: 3D Printing Revolutionizing the Medical Industry's Artificial Organ Development Segment - Research and Markets
New Report: Global mAb Biosimilars Market Spending to Grow at a CAGR of 4-7%, 2016-2020 - Key Vendors are Biocon, Celltrion, Dr. Reddy's Laboratories & Hospira - Research and Markets
Although 2015 may be rocky, both Baxter and Baxalta should see significant margin expansion and growth in the long term, says Morningstar's Karen Andersen.
Focus remains on hemophilia competition, but Baxter's comprehensive product portfolios are unmatched.
Standing out in a good year for stocks.